Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 165 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease

 		Sjögrens Disease, Systemic Lupus Erythematosus, Rheumatoid Arthritis Phase2 Canada
Czechia
Hungary
Italy
Poland
Spain
United States
View All
 NCT06293365

A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma

 		Asthma Phase3 Argentina
Austria
Colombia
Czechia
Greece
Guatemala
Hungary
Italy
Mexico
Panama
Portugal
Romania
South Africa
Spain
View All
 NCT05562466

ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients

 		Multiple Sclerosis, Relapsing-Remitting Italy NCT06345157

Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older).

 		Fascioliasis Phase4 Colombia
Egypt
Peru
Vietnam
View All
 NCT04230148

Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone

 		Advanced Solid Tumors Which Are cMET-dependent Phase2 China
Germany
Korea, Republic of
United States
View All
 NCT03040973

To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria

 		Severe Malaria Phase2 Burkina Faso
Congo, The Democratic Republic of the
Côte D'Ivoire
Gabon
India
Kenya
Mozambique
Nigeria
Rwanda
Uganda
View All
 NCT04675931

Home Reported Outcomes in PNH

 		Paroxysmal Nocturnal Hemoglobinuria United States NCT06411626

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

 		Diffuse Cutaneous Systemic Sclerosis Phase2 Austria
China
Germany
Greece
Hungary
India
Italy
Korea, Republic of
Poland
Portugal
Spain
Taiwan
Thailand
Turkey
United States
Vietnam
View All
 NCT06470048

A 24-week rPMS Study in Real-world Setting for Enerzair

 		Asthma Korea, Republic of NCT05274425

Migraine Survey in Gulf Region

 		Migraine United Arab Emirates NCT06237062